001     283088
005     20251231103633.0
024 7 _ |a 10.1002/alz70860_099453
|2 doi
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
037 _ _ |a DZNE-2025-01495
082 _ _ |a 610
100 1 _ |a Schwarck, Svenja
|0 P:(DE-2719)9000379
|b 0
|e First author
111 2 _ |a Alzheimer’s Association International Conference
|g AAIC 25
|c Toronto
|d 2025-07-27 - 2025-07-31
|w Canada
245 _ _ |a Role of physical fitness in resistance and cognitive resilience against age‐related pathology
260 _ _ |c 2025
336 7 _ |a Abstract
|b abstract
|m abstract
|0 PUB:(DE-HGF)1
|s 1767099421_6287
|2 PUB:(DE-HGF)
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|m journal
336 7 _ |a Output Types/Conference Abstract
|2 DataCite
336 7 _ |a OTHER
|2 ORCID
520 _ _ |a Background:Cognitive reserve (CR) and brain maintenance enable the brain to maintain performance despite injury and disease while also reducing neural decline by safeguarding brain structure and function. Physical activity is a potential pathway to BM and CR, as fitness relates to better cognition in older adults, though the underlying mechanisms remain unclear. To explore the role of physical fitness in BM and CR, we tested its association with brain pathology and its potential moderation of pathology's impact on cognitive performance.Method:We collected data from 167 cognitively unimpaired participants (mean age 71.57±7.50 years; 70 females) of the ongoing SFB1436 study (www.sfb1435.de; Figure 1). We collected many markers, including global and verbal cognitive performance; aerobic (VO2max) and muscular capacity; blood-based biomarkers of Alzheimer's disease (plasma Aβ1-42/1-40, ptau217) and plasticity (serum BDNF, VEGF and Cathepsin-B); PET-derived medial temporal lobe tau burden (MTL DVR, 18F-PI-2620 PET); and MRI-derived volumes of hippocampi, white matter hyperintensities, and perivascular spaces (PVS) in the basal ganglia (BG) and centrum semiovale regions. The tests were two-fold. We first tested whether fitness was associated with lower MTL DVR values, reduced MRI-derived volumes of brain pathology, and better cognition. Using moderation analysis, we then tested whether physical fitness moderated the relationship between pathology and cognition. We relied on ANOVA for model comparison. We adjusted models for age and sex and FDR-corrected multiple comparisons.Result:Participants with better aerobic capacity (VO2max) had lower BG-PVS volumes (Figure 2a) and better global cognitive performance. Those with higher MTL tau burden had worse verbal memory (Figure 2b). We found no evidence of a relationship between physical fitness and Alzheimer's markers, plasticity-related markers, or hippocampal volume. Moderation analysis revealed that physical fitness did not moderate the relationship between MTL tau burden and verbal memory, but model comparison revealed weak evidence for CR against MTL tau.Conclusion:We demonstrated that aerobic fitness is related to lower BG-PVS volumes in old age and showed that aerobic fitness tends to act as CR proxy against MTL tau pathology. Aerobic fitness may help maintain cerebrovascular and glymphatic dysfunction in old age, thereby mitigating cognitive decline.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Behrenbruch, Niklas
|0 P:(DE-2719)9002133
|b 1
|u dzne
700 1 _ |a Schumann-Werner, Beate
|0 P:(DE-2719)9002320
|b 2
|u dzne
700 1 _ |a Vockert, Niklas
|0 P:(DE-2719)9000804
|b 3
|u dzne
700 1 _ |a Müller, Patrick
|0 P:(DE-2719)2811487
|b 4
|u dzne
700 1 _ |a Moyano, Jose Bernal
|0 P:(DE-2719)9001989
|b 5
|u dzne
700 1 _ |a Duarte, Roberto
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Hernandez, Maria del C. Valdes
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Wardlaw, Joanna M
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Garcia-Garcia, Berta
|0 P:(DE-2719)2812734
|b 9
|u dzne
700 1 _ |a Fischer, Larissa
|0 P:(DE-2719)9002356
|b 10
|u dzne
700 1 _ |a Molloy, Eóin N.
|0 P:(DE-2719)9002180
|b 11
700 1 _ |a Hochkeppler, Anne
|0 P:(DE-2719)2812346
|b 12
|u dzne
700 1 _ |a Incesoy, Enise I
|0 P:(DE-2719)9001517
|b 13
|u dzne
700 1 _ |a Rullmann, Michael
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Stephens, Andrew W.
|b 15
700 1 _ |a Patt, Marianne
|b 16
700 1 _ |a Barthel, Henryk
|b 17
700 1 _ |a Schildan, Andreas
|b 18
700 1 _ |a Marcos Morgado, Barbara
|0 P:(DE-2719)9003591
|b 19
|u dzne
700 1 _ |a Esselmann, Hermann
|b 20
700 1 _ |a Wiltfang, Jens
|0 P:(DE-2719)2811317
|b 21
|u dzne
700 1 _ |a Sabri, Osama
|0 P:(DE-2719)2814810
|b 22
|u dzne
700 1 _ |a Kreißl, Michael
|0 P:(DE-2719)2812799
|b 23
|u dzne
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 24
|u dzne
700 1 _ |a Maass, Anne
|0 P:(DE-2719)2811815
|b 25
|e Last author
|u dzne
773 _ _ |a 10.1002/alz70860_099453
|g Vol. 21, no. S6, p. e099453
|0 PERI:(DE-600)2201940-6
|n S6
|p e099453
|t Alzheimer's and dementia
|v 21
|y 2025
|x 1552-5260
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/283088/files/DZNE-2025-1495.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/283088/files/DZNE-2025-1495.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:283088
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000379
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002133
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002320
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000804
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811487
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9001989
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2812734
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)9002356
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)9002180
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2812346
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)9001517
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 19
|6 P:(DE-2719)9003591
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2811317
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 22
|6 P:(DE-2719)2814810
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 23
|6 P:(DE-2719)2812799
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 24
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)2811815
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1311001
|k AG Maaß
|l Multimodal Neuroimaging
|x 0
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 1
920 1 _ |0 I:(DE-2719)1310003
|k AG Müller
|l Neuroprotection
|x 2
920 1 _ |0 I:(DE-2719)1410006
|k AG Wiltfang
|l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases
|x 3
980 _ _ |a abstract
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a journal
980 _ _ |a I:(DE-2719)1311001
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1310003
980 _ _ |a I:(DE-2719)1410006
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21